A PEEK into carbon fiber: A practical guide for high performance composite polymeric implants for orthopaedic oncology.

Carbon fiber implants Composite polymer Orthopaedic oncology Practical guide

Journal

Journal of orthopaedics
ISSN: 0972-978X
Titre abrégé: J Orthop
Pays: India
ID NLM: 101233220

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 03 07 2023
accepted: 25 09 2023
pmc-release: 01 11 2024
medline: 12 10 2023
pubmed: 12 10 2023
entrez: 12 10 2023
Statut: epublish

Résumé

The use of carbon fiber implants in orthopaedic oncology has increased within recent years. The most widely used type of polymer is carbon fiber polyether ether ketone (CF-PEEK). Its radiolucency enables targeted radiotherapy and artifact-free tumor surveillance, which provides major advantages over metallic hardware. We aim to summarize the unique benefits within orthopaedic oncology, clinical pitfalls, and recent advancements. Four representative patient cases from a single tertiary academic medical center were treated with carbon fiber implants (n = 2 nails, n = 2 plates) from 2021 to 2022. There were no adverse events noted during intraoperative implantation or postoperative follow up. All patients reported improvements in pain and no difficulties in ambulation. There were no instances of catastrophic failure or implant loosening. CF implants offer a diverse array of advantages regarding its radiolucency, low scatter density, and bioinert profile. Nonetheless, further research is required to understand the long-term surgical outcomes and robustness of CF implants. Multi institutional trials could address important aspects of durability and stability over extended periods, feasibility and ease-of-use for different anatomical sites and bone quality, as well as cost-effectiveness in post-operative imaging, healthcare resource utilization, and revision rates. Providing orthopaedic surgeons with valuable insight will enable thorough clinically supported, informed decision making regarding optimal use of implants.

Identifiants

pubmed: 37822644
doi: 10.1016/j.jor.2023.09.011
pii: S0972-978X(23)00221-0
pmc: PMC10562613
doi:

Types de publication

Journal Article

Langues

eng

Pagination

13-18

Informations de copyright

© 2023 Published by Elsevier B.V. on behalf of Professor P K Surendran Memorial Education Foundation.

Déclaration de conflit d'intérêts

Author #8 is a paid speaker for CarboFix and Daiichi Sankyo; he is a paid consultant for ONKOS and IlluminOss Medical. He currently serves as a committee member for the Musculoskeletal Tumor Society. The remaining authors have no competing interests to declare.

Références

Drug Deliv. 2020 Dec;27(1):791-804
pubmed: 32420760
J Appl Biomater. 1990 Spring;1(1):57-78
pubmed: 10148987
Pract Radiat Oncol. 2023 May-Jun;13(3):256-262
pubmed: 36738918
Injury. 2017 Oct;48 Suppl 3:S55-S59
pubmed: 29025611
Clin Orthop Relat Res. 2021 Apr 1;479(4):674-678
pubmed: 33704105
Fibers (Basel). 2016;4(1):
pubmed: 26966555
Eur J Trauma Emerg Surg. 2022 Jun;48(3):2387-2406
pubmed: 34487201
Trauma Case Rep. 2021 Jun 16;34:100493
pubmed: 34195336
Biomaterials. 2007 Nov;28(32):4845-69
pubmed: 17686513
Med Phys. 2012 Dec;39(12):7507-17
pubmed: 23231300
Sci Rep. 2022 Nov 8;12(1):18969
pubmed: 36348055
Acta Orthop. 2009 Feb;80(1):135-8
pubmed: 19297794
Injury. 2011 Apr;42(4):424-6
pubmed: 21130437
Polymers (Basel). 2022 Oct 29;14(21):
pubmed: 36365594
J Bone Joint Surg Br. 2002 Nov;84(8):1093-110
pubmed: 12463652
Front Immunol. 2019 Nov 08;10:2662
pubmed: 31781128
Adv Radiat Oncol. 2021 Feb 07;6(3):100665
pubmed: 33817411
Biomaterials. 2006 Jan;27(3):324-34
pubmed: 16115677
PLoS One. 2022 Nov 8;17(11):e0277332
pubmed: 36346802
Adv Drug Deliv Rev. 2013 Dec;65(15):2111-9
pubmed: 24184372
J Bone Joint Surg Am. 2011 Jan 19;93(2):207-12
pubmed: 21248220
J Nucl Med Technol. 2005 Sep;33(3):156-61; quiz 163-4
pubmed: 16145223
J Mech Behav Biomed Mater. 2016 Feb;54:223-8
pubmed: 26476965
J Bone Joint Surg Am. 2012 Sep 19;94(18):1655-61
pubmed: 23289127
J Neurosurg Spine. 2016 Aug;25(2):248-55
pubmed: 27058498
EFORT Open Rev. 2022 Aug 04;7(8):611-617
pubmed: 35924657
Metals (Basel). 2014 Dec;4(4):549-569
pubmed: 25635227
World J Surg Oncol. 2018 Dec 28;16(1):241
pubmed: 30593277
J Bone Joint Surg Am. 2013 Mar 20;95(6):512-8
pubmed: 23515985
J Mech Behav Biomed Mater. 2013 May;21:37-46
pubmed: 23455331
Sci Rep. 2022 Feb 16;12(1):2607
pubmed: 35173195
J Bone Joint Surg Am. 2021 Feb 3;103(3):257-263
pubmed: 33315696
Eur J Orthop Surg Traumatol. 2020 May;30(4):643-651
pubmed: 31865455
Bone Jt Open. 2022 Aug;3(8):648-655
pubmed: 35983704
Acta Biomater. 2013 May;9(5):6663-74
pubmed: 23337705
JBJS Case Connect. 2020 Jul-Sep;10(3):e20.00041
pubmed: 32910577
JBJS Case Connect. 2018 Oct-Dec;8(4):e83
pubmed: 30601766
J Orthop Trauma. 2008 Jan;22(1):30-6
pubmed: 18176162
J Arthroplasty. 2002 Feb;17(2):217-23
pubmed: 11847623
J Spine Surg. 2017 Sep;3(3):323-329
pubmed: 29057339
Phys Imaging Radiat Oncol. 2022 Nov 12;24:138-143
pubmed: 36411857
Nanomaterials (Basel). 2022 Sep 02;12(17):
pubmed: 36080092
Sci Rep. 2017 Jan 06;7:39612
pubmed: 28059080
Skeletal Radiol. 2022 Dec;51(12):2237-2244
pubmed: 35761094
Biomaterials. 2002 Apr;23(8):1749-59
pubmed: 11950045
J Clin Med. 2022 Aug 24;11(17):
pubmed: 36078889
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1224-31
pubmed: 15927413

Auteurs

Marilee J Clunk (MJ)

Musculoskeletal Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital Boston, MA, 02114, USA.
University of Toledo College of Medicine and Life Sciences Toledo, OH, 43614, USA.

Marcos R Gonzalez (MR)

Musculoskeletal Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital Boston, MA, 02114, USA.

Hayley M Denwood (HM)

Musculoskeletal Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital Boston, MA, 02114, USA.
Boston University Chobanian and Avedisian School of Medicine Boston, MA, 02118, USA.

Joseph O Werenski (JO)

Musculoskeletal Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital Boston, MA, 02114, USA.

Alisha Sodhi (A)

Musculoskeletal Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital Boston, MA, 02114, USA.

Brett A Hoffman (BA)

University of Toledo College of Medicine and Life Sciences Toledo, OH, 43614, USA.

Nelson Merchan (N)

Musculoskeletal Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital Boston, MA, 02114, USA.

Santiago A Lozano-Calderon (SA)

Musculoskeletal Oncology Service, Department of Orthopaedic Surgery, Massachusetts General Hospital Boston, MA, 02114, USA.

Classifications MeSH